Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Solesence (SLSN) EBITDA (2016 - 2025)

Solesence (SLSN) has disclosed EBITDA for 16 consecutive years, with -$781000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBITDA fell 124.41% year-over-year to -$781000.0, compared with a TTM value of -$3.0 million through Sep 2025, down 149.84%, and an annual FY2024 reading of $937000.0, up 201.74% over the prior year.
  • EBITDA was -$781000.0 for Q3 2025 at Solesence, down from $1.9 million in the prior quarter.
  • Across five years, EBITDA topped out at $3.2 million in Q3 2024 and bottomed at -$4.4 million in Q4 2024.
  • Average EBITDA over 5 years is $70894.7, with a median of $256000.0 recorded in 2025.
  • The sharpest move saw EBITDA surged 1255.81% in 2021, then tumbled 1056.19% in 2023.
  • Year by year, EBITDA stood at -$2.4 million in 2021, then surged by 93.86% to -$145000.0 in 2022, then skyrocketed by 602.07% to $728000.0 in 2023, then tumbled by 706.87% to -$4.4 million in 2024, then soared by 82.32% to -$781000.0 in 2025.
  • Business Quant data shows EBITDA for SLSN at -$781000.0 in Q3 2025, $1.9 million in Q2 2025, and $256000.0 in Q1 2025.